RxDoctor Payments Data

Al Haitham Al Shetawi, DMD

Oral & Maxillofacial Surgery · Poughkeepsie, NYNPI 1871760314

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Regeneron Healthcare Solutions, Inc. accounts for 93.4% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $26,754, more than ten times the $125 reported in 2019. Among oral & maxillofacial surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,513in general payments, 2019–2025

Across 41 payments — averaging $671.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$26K
  • Medical Device Business Services, Inc.$1K
  • Johnson & Johnson$150
  • Boehringer Ingelheim$125
  • Biosense Webster, Inc.$125
  • Stryker$93
  • plus $156 from 4 others

What the payments were for

  • Consulting fees$9,60035%
  • Speaking & faculty fees$13,40849%
  • Travel & lodging$2,69210%
  • Food & beverage$1,8137%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,513 in reported general payments places this provider in the 95th percentile of 605 oral & maxillofacial surgery providers in New York.

See all oral & maxillofacial surgery providers in New York

Medicare billing

Part B allowed, 2024
$211,257
Medicare patients
278
Services billed
707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other oral & maxillofacial surgery in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →